AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
187.10
+3.93 (2.15%)
At close: Jan 30, 2026

AstraZeneca Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
289,368203,171209,268209,442182,034131,259
Market Cap Growth
37.06%-2.91%-0.08%15.06%38.68%-0.69%
Enterprise Value
314,437228,175234,801238,391209,520149,836
Last Close Price
187.10127.23130.76132.48112.6798.23
PE Ratio
30.7928.8835.1463.701625.3141.07
PS Ratio
4.983.764.574.724.874.93
PB Ratio
6.294.975.345.654.638.39
P/FCF Ratio
22.8620.4523.2924.0337.3634.20
P/OCF Ratio
19.1117.1320.2321.3530.5327.35
EV/Sales Ratio
5.304.225.135.385.605.63
EV/EBITDA Ratio
14.8512.9916.5117.3531.2721.44
EV/EBIT Ratio
19.3817.6524.3427.0572.3234.29
EV/FCF Ratio
24.8422.9626.1427.3543.0139.04
Debt / Equity Ratio
0.710.750.760.840.851.45
Debt / EBITDA Ratio
1.571.702.042.234.813.15
Debt / FCF Ratio
2.583.073.303.576.855.92
Asset Turnover
0.530.530.460.440.440.42
Inventory Turnover
1.591.801.591.261.851.45
Quick Ratio
0.690.670.580.620.670.67
Current Ratio
0.880.930.820.861.160.96
Return on Equity (ROE)
21.67%17.59%15.64%8.63%0.42%20.80%
Return on Assets (ROA)
9.06%7.88%6.10%5.46%2.10%4.26%
Return on Invested Capital (ROIC)
18.54%16.27%13.35%13.75%6.00%11.87%
Return on Capital Employed (ROCE)
19.80%17.00%13.70%12.60%3.50%9.40%
Earnings Yield
3.25%3.46%2.85%1.57%0.06%2.44%
FCF Yield
4.37%4.89%4.29%4.16%2.68%2.92%
Dividend Yield
1.71%2.44%2.22%2.19%2.55%2.85%
Payout Ratio
52.89%65.80%75.25%132.72%3442.86%111.77%
Buyback Yield / Dilution
0.08%-0.06%-0.13%-9.32%-8.68%-0.92%
Total Shareholder Return
1.79%2.37%2.09%-7.13%-6.13%1.93%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.